Literature DB >> 7251890

A hemalog D analysis of chronic lymphocytic leukaemia and other lymphoproliferative disorders affecting the blood.

K G Patterson, A H Goldstone, J D Richards, J C Cawley.   

Abstract

A correlative clinical and Hemalog D study of 80 cases of chronic lymphocytic leukaemia (CLL) was performed and the results compared with those in other lymphoproliferative disorders affecting the blood (eight cases of hairy-cell leukaemia, HCL; three cases of prolymphocytic leukaemia, PLL: two cases of lymphoplasmacytoid proliferation, LPP; and one case of Sézary's syndrome, SS). In CLL the mean percentage and absolute counts of large unstained cells (LUC) were 8.7% and 6.2 x 109/1 (6200/mm3), and the percentage of LUCs was not substantially affected by treatment; there was no correlation between LUCs and Rai clinical stage. SS and LPP were characterised by a similar percentage of LUCs, but both HCL and PLL were distinguished by a higher mean percentage of LUCs. Stage IV CLL was associated with monocytopenia, but other stages of CLL, PLL, LPP, and SS showed no consistent reduction of absolute numbers of non-lymphoid cell types. In contrast, HCL was characterised by a consistent absolute neutropenia and monocytopenia which distinguished its Hemalog D profile from that of PLL.

Entities:  

Mesh:

Year:  1981        PMID: 7251890      PMCID: PMC493327          DOI: 10.1136/jcp.34.5.473

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  Morphology of chronic lymphocytic leukemia and its relationship to survival.

Authors:  L C Peterson; C D Bloomfield; R D Sundberg; K J Gajl-Peczalska; R D Brunning
Journal:  Am J Med       Date:  1975-09       Impact factor: 4.965

2.  Clinical staging of chronic lymphocytic leukemia.

Authors:  K R Rai; A Sawitsky; E P Cronkite; A D Chanana; R N Levy; B S Pasternack
Journal:  Blood       Date:  1975-08       Impact factor: 22.113

3.  A clinical staging system for chronic lymphocytic leukemia: prognostic significance.

Authors:  J L Binet; M Leporrier; G Dighiero; D Charron; P D'Athis; G Vaugier; H M Beral; J C Natali; M Raphael; B Nizet; J Y Follezou
Journal:  Cancer       Date:  1977-08       Impact factor: 6.860

4.  Investigation of a new parameter in chronic lymphocytic leukemia: the percentage of large peripheral lymphocytes determined by the Hemalog D. Prognostic significance.

Authors:  J L Binet; G Vaugier; G Dighiero; P d'Athis; D Charron
Journal:  Am J Med       Date:  1977-11       Impact factor: 4.965

Review 5.  Combination chemotherapy of advanced Hodgkin's disease. A review.

Authors:  M A Goldsmith; S K Carter
Journal:  Cancer       Date:  1974-01       Impact factor: 6.860

6.  Cell volume studies in B-cell leukaemia.

Authors:  C Costello; J Wardle; D Catovsky; S M Lewis
Journal:  Br J Haematol       Date:  1980-06       Impact factor: 6.998

7.  Prognostic value of nucleoli and cell size in chronic lymphocytic leukemia.

Authors:  H N Dubner; J J Crowley; R F Schilling
Journal:  Am J Hematol       Date:  1978       Impact factor: 10.047

8.  Structural and functional properties of the "hairy" cells of leukemic reticuloendotheliosis.

Authors:  R C Braylan; E S Jaffe; T J Triche; K Nanba; B J Fowlkes; H Metzger; M M Frank; M S Dolan; C L Yee; I Green; C W Berard
Journal:  Cancer       Date:  1978-01       Impact factor: 6.860

9.  Relationship of clinical staging and lymphocyte morphology to survival in chronic lymphocytic leukaemia.

Authors:  L C Peterson; C D Bloomfield; R D Brunning
Journal:  Br J Haematol       Date:  1980-04       Impact factor: 6.998

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.